FAM76A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.42999999999771E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.579900E-03 |
Normal-vs-Stage2 |
5.853700E-02 |
Normal-vs-Stage3 |
2.50840000004526E-06 |
Normal-vs-Stage4 |
3.75069997282651E-09 |
Stage1-vs-Stage2 |
6.313400E-01 |
Stage1-vs-Stage3 |
3.901000E-03 |
Stage1-vs-Stage4 |
3.92850000000555E-05 |
Stage2-vs-Stage3 |
1.650220E-01 |
Stage2-vs-Stage4 |
2.213900E-02 |
Stage3-vs-Stage4 |
2.093600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.60261999999634E-05 |
Normal-vs-AfricanAmerican |
3.3403000032628E-08 |
Normal-vs-Asian |
8.911400E-01 |
Caucasian-vs-AfricanAmerican |
6.982700E-03 |
Caucasian-vs-Asian |
2.041400E-01 |
AfricanAmerican-vs-Asian |
1.369810E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.8449000000208E-07 |
Normal-vs-Female |
6.084200E-03 |
Male-vs-Female |
2.884300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.99548999999521E-05 |
Normal-vs-Age(41-60Yrs) |
1.517300E-03 |
Normal-vs-Age(61-80Yrs) |
9.77959999981515E-07 |
Normal-vs-Age(81-100Yrs) |
1.651600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.316200E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.021000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.118800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.269420E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.197200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.724800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.834200E-01 |
Normal-vs-Grade 2 |
1.900440E-01 |
Normal-vs-Grade 3 |
4.75389999587961E-08 |
Normal-vs-Grade 4 |
1.7927881401647E-12 |
Grade 1-vs-Grade 2 |
3.568600E-01 |
Grade 1-vs-Grade 3 |
5.604800E-03 |
Grade 1-vs-Grade 4 |
2.45269999999964E-05 |
Grade 2-vs-Grade 3 |
1.94825999999537E-05 |
Grade 2-vs-Grade 4 |
1.94389948582341E-10 |
Grade 3-vs-Grade 4 |
5.386200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.407800E-01 |
Normal-vs-ccB subtype |
3.79696274421804E-13 |
ccA subtype-vs-ccB subtype |
1.62414526272414E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.629400E-04 |
Normal-vs-N1 |
7.20610005000566E-09 |
N0-vs-N1 |
4.599900E-03 |
|
|